Prescription drug · ANDA
Oseltamivir Phosphate (Oseltamivir) NDC 60219-1266
Oseltamivir phosphate 75 mg/1 · Capsule · Oral · Amneal Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60219-1266-1 | 6021912660160219126601 | 1 BLISTER PACK in 1 CARTON (60219-1266-1) / 10 CAPSULE in 1 BLISTER PACKMarketed from Sep 27, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Oseltamivir Phosphate
- Generic name (nonproprietary)
- oseltamivir
- Active ingredients
- Oseltamivir phosphate — 75 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals LLCNDC labeler code 60219
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209093
- Marketing start
- Listing expires
- Other FDA classes
- Neuraminidase Inhibitors (Mechanism)
- Identifiers
- Product ID 60219-1266_10f81f1e-ff47-4b45-8ed1-a2c795418aedSPL ID 10f81f1e-ff47-4b45-8ed1-a2c795418aed
- Pharmacologic class
- Neuraminidase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N460219126601followed by a unit qualifier and the quantityPackage 60219-1266-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 60219-1266
- What is NDC 60219-1266?
- 60219-1266 is the product NDC for Oseltamivir Phosphate (oseltamivir), Oseltamivir phosphate 75 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Oseltamivir Phosphate (Oseltamivir).
- What is the active ingredient?
- Oseltamivir phosphate.
- Who is the labeler?
- Amneal Pharmaceuticals LLC, NDC labeler code 60219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Oseltamivir Phosphate?
- 107 other product NDCs are listed under this name. See all Oseltamivir Phosphate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Oseltamivir Phosphate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Oseltamivir Phosphate | Oseltamivir phosphate 75 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4770 | 70518-4770-00 |
| Oseltamivir Phosphate | Oseltamivir phosphate 6 mg/mL | For suspensionOral | Alembic Pharmaceuticals Limited | 46708-769 | 46708-0769-60 |
| Oseltamivir Phosphate | Oseltamivir phosphate 6 mg/mL | For suspensionOral | Alembic Pharmaceuticals Inc. | 62332-769 | 62332-0769-60 |
| Oseltamivir Phosphate | Oseltamivir phosphate 6 mg/mL | SuspensionOral | HEC Pharm USA Inc. | 72303-0851 | 72303-0851-01 |
| Oseltamivir Phosphate | Oseltamivir phosphate 75 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-4066 | 68788-4066-01 |
| oseltamivir phosphate | Oseltamivir phosphate 30 mg/1 | CapsuleOral | Zhejiang Poly Pharm. Co., Ltd. | 72673-101 | 72673-0101-10 |
| oseltamivir phosphate | Oseltamivir phosphate 45 mg/1 | CapsuleOral | Zhejiang Poly Pharm. Co., Ltd. | 72673-102 | 72673-0102-10 |
| Oseltamivir phosphate | Oseltamivir phosphate 45 mg/1 | CapsuleOral | Shandong New Time Pharmaceutical Co., Ltd. | 42677-321 | 42677-0321-01 |
| Oseltamivir phosphate | Oseltamivir phosphate 30 mg/1 | CapsuleOral | Shandong New Time Pharmaceutical Co., Ltd. | 42677-320 | 42677-0320-01 |
| Oseltamivir phosphate | Oseltamivir phosphate 75 mg/1 | CapsuleOral | Shandong New Time Pharmaceutical Co., Ltd. | 42677-322 | 42677-0322-01 |
Other NDCs under ANDA 209093
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Oseltamivir Phosphateoseltamivir | Oseltamivir phosphate 75 mg/1 | CapsuleOral | AvKARE | 42291-664 |
| Oseltamivir Phosphateoseltamivir | Oseltamivir phosphate 30 mg/1 | CapsuleOral | AvKARE | 42291-666 |
| Oseltamivir Phosphateoseltamivir | Oseltamivir phosphate 30 mg/1 | CapsuleOral | Amneal Pharmaceuticals LLC | 60219-1264 |
| Oseltamivir Phosphateoseltamivir | Oseltamivir phosphate 45 mg/1 | CapsuleOral | Amneal Pharmaceuticals LLC | 60219-1265 |
| Oseltamivir Phosphateoseltamivir | Oseltamivir phosphate 30 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1264 |
| Oseltamivir Phosphateoseltamivir | Oseltamivir phosphate 45 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1265 |
| Oseltamivir Phosphateoseltamivir | Oseltamivir phosphate 75 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1266 |